Specialty Pharmacy

REMS deemed unnecessary to ensure drug benefits outweigh risks.

Traveling a longer distance to a medical center was not associated with spending more time on a waiting list.

C-reactive protein is useful in the diagnosis and treatment of some acute or chronic inflammatory conditions.

Health-system pharmacists will inevitably face growing ethical challenges as their roles in patient care continue to evolve.

Out-of-pocket costs to remain a significant hurdle for patients even after closing of coverage gap.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the trend of larger entities absorbing independent specialty pharmacies.

Prescription drugs costs for patients with psoriatic arthritis tended to be higher than comparable costs for ankylosing spondylitis.

A report by STAT has found that a majority of institutions conducting clinical trials fail to report their results to the web site ClinicalTrials.gov.

Fatigue had a strong association with pain intensity and interference in inflammatory bowel disease.

Patients who receive an overdose of chemotherapy drugs will now have access to an emergency treatment called uridine triacetate.

Bendeka was approved for indolent B-cell non-Hodgkin lymphoma that progressed during or within 6 months of treatment with a rituximab regimen.

Researchers weigh risk and reward in starting early antiretroviral therapy in patients with HIV.

Liver conserving treatments are sorely needed.

Patients with chronic conditions like HIV and hepatitis C could no longer be denied coverage due to pre-existing conditions under the ACA.

Prolonged steroid treatment may put inflammatory bowel disease patients at greater risk for steroid-associated adverse events.

Test diagnoses RA with better accuracy by detecting synthetic citrullinated peptides.

LQG participants show improvements in lung function, overall health, mental health, and quality of life.

Diabetes has a tremendous global impact, but developing nations often struggle to help patients deal with their disease.

Trial data shows positive results across a range of difficult-to-treat patients with MM.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.

Research may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.

HIMSS is working to determine the readiness of providers to participate in the types of value-based payment models that CMS is moving toward.

Researchers examine impact of probiotics on inflammatory bowel disease.

XSTAT 30 is typically used to control life-threatening bleeding in military settings.

A pharmacy must pay $60,000 in a settlement resolving allegations that it violated the Controlled Substances Act and the Combat Methamphetamine Epidemic Act of 2005.

An HCV vaccine, while elusive, offers the best hope to eradicate the virus.

Top news of the week in cancer drug development.

Eating before bed can have a significant impact on the development of nonalcoholic fatty liver disease.

Researchers consider the ramifications of using organs from infected patients to save lives.

Liver damage caused by hepatitis C may eventually be overcome through stem cell therapy.